InvestorsHub Logo
Followers 44
Posts 4950
Boards Moderated 0
Alias Born 04/30/2005

Re: Doc328 post# 421852

Friday, 07/07/2023 12:34:26 PM

Friday, July 07, 2023 12:34:26 PM

Post# of 469992
Quote: "I think neuroinflammation is a great target for AD and drugs that regulate microglia/macroglia or promote M1 to M2 phenotype switching are reasonable to trial for this indication."

Wow...it's nice to see that you have finally accepted this MOA to address AD. (Very encouraging!)

Thanks for your perspective.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News